Companies

Summit Therapeutics Inc. (SMMT) SEC filings

CIK 0001599298 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2020
Revenue (USD)01.8 M
Net income (USD)-29.1 M
Diluted EPS (USD/shares)-1.44-0.41

Latest filings

FiledFormDescriptionPeriod
2026-10-19DEF 14ADEF 14A2026-11-04
2026-10-144FORM 42026-10-08
2026-10-06PRE 14APRE 14A2026-10-06
2026-09-298-K8-K items 1.01,3.02,5.03,8.01,9.012026-09-28
2026-09-158-K8-K items 8.01,9.012026-09-15
2026-09-148-K8-K items 8.01,9.012026-09-13
2026-09-038-K8-K items 8.01,9.012026-09-02
2026-08-268-K8-K items 8.01,9.012026-08-25
2026-08-058-K8-K items 8.01,9.012026-08-05
2026-07-238-K8-K items 1.01,9.012026-07-23
2026-07-23424B5424B5
2026-07-2310-Q10-Q2026-06-30
2026-07-238-K8-K items 2.02,7.01,9.012026-07-23
2026-07-228-K8-K items 8.01,9.012026-07-22
2026-06-128-K8-K items 5.072026-06-10
2026-06-124FORM 42026-06-12
2026-06-124FORM 42026-06-12
2026-06-118-K8-K items 7.012026-06-10
2026-06-10424B5424B5
2026-06-09S-3ASRS-3ASR
2026-06-044FORM 42026-06-04
2026-06-044FORM 42026-06-04
2026-06-044FORM 42026-06-04
2026-06-038-K8-K items 8.012026-06-02
2026-06-018-K8-K items 8.01,9.012026-05-30

Forms on file (last 1,000): 8-K 125, 6-K 115, 4 106, SC 13D/A 22, 3 21, 10-Q 18, UPLOAD 14, CT ORDER 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=SMMT (0.002 USD), /gw/filings/filings?ticker=SMMT&form=8-K, /gw/filings/facts?ticker=SMMT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange